About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline



2026 Op. N.M. Att'y Gen. 1 (2026)

handle is hein.sag/sagnm0112 and id is 1 raw text is: 


           New Mexico
           Department
           of Justice


                                     January 9, 2026


   OPINION
      OF                                                             Opinion No. 2026-01
RAUL   TORREZ
Attorney General


To:    State Representative Andrea Reeb

Re:    Attorney General Opinion - Permissible Use of Opioid Settlement Money


                                        Question

Is it permissible for Curry County and the City of Clovis to use opioid settlement funds distributed
through the New  Mexico  Opioid Allocation Agreement  to partially fund a behavioral health
facility that will undoubtedly-but not specifically-provide services to individuals suffering
from opioid use disorder?
                                      Short Answer

Based on the question posed, such use is not permitted. The use of these funds to build a general
behavioral health facility is not permitted, even if some of the patients ultimately treated at the
facility suffer from opioid use disorder. In order to make use of the funds, a more precise allocation
of the funds to address opioid issues is necessary. For instance, it may be permissible to use the
funds to pay operational expenses of the facility, in proportion to the percentage of expenses used
to treat opioid patients.

                                      Background

As a consequence of the harms caused by opioid use and abuse, the State of New Mexico, along
with other states and political subdivisions, filed a series of lawsuits against pharmaceutical
manufacturers, distributers, and retailers. See, e.g., State ex relBalderas, D-101-CV-2017-02541
(N.M. 1St Jud. Dist., filed Sept. 7, 2017). These lawsuits resulted in several very similar settlement
agreements  with various entities in the pharmaceutical industry. New Mexico entered into
agreements  with Johnson  &  Johnson  (a/k/a Janssen), Allergan, Teva Pharmaceuticals, the
pharmaceutical distributors, and some smaller companies  (Settlement Agreements). New
Mexico's agreement with Johnson & Johnson (Janssen Settlement Agreement) is representative
of these Settlement Agreements.



                              New Mexico Department of Justice
               408 Galisteo Street I Santa Fe, NM 87501 (505) 490-4060 1 NMDOJ.GOV